AMAT
60
-4
GILD
50
13
LLY
73
-3
BAX
41
3
AKAM
48
-11
SIG
47
-3
FE
41
2
MDT
44
5
SJM
29
-2
CTAS
64
2
DO
45
2
MUR
26
-3
RHI
43
15
PDCO
57
2
GOOG
83
4
ADT
55
25
CHK
5
-7
EXC
47
2
JNPR
56
2
CL
77
2
AMAT
60
-4
GILD
50
13
LLY
73
-3
BAX
41
3
AKAM
48
-11
SIG
47
-3
FE
41
2
MDT
44
5
SJM
29
-2
CTAS
64
2
DO
45
2
MUR
26
-3
RHI
43
15
PDCO
57
2
GOOG
83
4
ADT
55
25
CHK
5
-7
EXC
47
2
JNPR
56
2
CL
77
2
Financhill
Back

Qiagen NV Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
42

QGEN
Qiagen NV

Last Price:
41.85
Seasonality Move:
1.25%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
42
Qiagen NV (QGEN) is a Sell

Is Qiagen NV a Buy, Sell or Hold?

  • The current Qiagen NV [QGEN] share price is $41.86. The Score for QGEN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • QGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QGEN Stock Price Chart

What is Qiagen NV's stock price today?

  • The Qiagen NV share price today is $41.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QGEN is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

QGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 39.77 Sell
Chaikin Money Flow: 1755382 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.74 - 44.96) Sell
Bollinger Bands (100): (41.72 - 44.54) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

QGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.14 Sell
20-day SMA: 43.52 Sell
50-day SMA: 42.94 Sell
200-day SMA: 42.72 Sell
8-day EMA: 42.98 Sell
20-day EMA: 43.43 Sell
50-day EMA: 43.34 Sell
200-day EMA: 43.65 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Qiagen NV Earnings Growth & QGEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.01 per share, an increase this year of $0.00 per share, and an increase next year of $0.17 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Qiagen NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):